RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D‑galactose and aluminum‑induced …
F Han, H Xu, JX Shen, C Pan, ZH Yu, JJ Chen… - Acta Neurobiologiae …, 2020 - ane.pl
Alzheimer's disease (AD) has become the most prevalent neurodegenerative disorder.
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
[PDF][PDF] RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D‑galactose and aluminum …
F Han, H Xu, JX Shen, C Pan, ZH Yu… - Acta …, 2020 - pdfs.semanticscholar.org
Dementia is one of the major causes of disability and dependency among older people
worldwide. Every year, there are nearly 10 million new cases (WHO, 2019). Alzheimer …
worldwide. Every year, there are nearly 10 million new cases (WHO, 2019). Alzheimer …
RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D-galactose and aluminum‑induced …
F Han, H Xu, JX Shen, C Pan, ZH Yu… - Acta …, 2020 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) has become the most prevalent neurodegenerative disorder.
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D-galactose and aluminum‑induced …
F Han, H Xu, JX Shen, C Pan, ZH Yu… - Acta Neurobiologiae …, 2020 - europepmc.org
Alzheimer's disease (AD) has become the most prevalent neurodegenerative disorder.
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D‑galactose and aluminum‑induced …
F Han, H Xu, JX Shen, C Pan, ZH Yu… - Acta Neurobiologiae …, 2020 - agro.icm.edu.pl
Alzheimer's disease (AD) has become the most prevalent neurodegenerative disorder.
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
[PDF][PDF] RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D‑galactose and aluminum …
F Han, H Xu, JX Shen, C Pan, ZH Yu, JJ Chen… - Acta Neurobiol …, 2020 - scholar.archive.org
Dementia is one of the major causes of disability and dependency among older people
worldwide. Every year, there are nearly 10 million new cases (WHO, 2019). Alzheimer …
worldwide. Every year, there are nearly 10 million new cases (WHO, 2019). Alzheimer …
RhoA/Rock2/Limk1/cofilin1 pathway is involved in attenuation of neuronal dendritic spine loss by paeonol in the frontal cortex of D-galactose and aluminum‑induced …
F Han, H Xu, JX Shen, C Pan, ZH Yu… - Acta Neurobiologiae …, 2020 - europepmc.org
Alzheimer's disease (AD) has become the most prevalent neurodegenerative disorder.
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …
Given the pathogenesis of AD is unclear, there is currently no drug approved to halt or delay …